Jianbo Wu
- Cancer Research top 5%
- MicroRNA in disease regulation 15
- Protease and Inhibitor Mechanisms 12
- Internal Medicine top 5%
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 12
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 12
- Platelet Disorders and Treatments 8
- Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer 20
-
- Adipokines, Inflammation, and Metabolic Diseases 15
-
- Advanced Glycation End Products research 10
- Journals
- Journal of Biological Chemistry (2 papers)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Jianbo Wu
112 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 481
- Internal Medicine 96
- Immunology and Allergy 94
- Hematology 166
- Molecular Biology 989
Countries citing papers authored by Jianbo Wu
This map shows the geographic impact of Jianbo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianbo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianbo Wu more than expected).
Fields of papers citing papers by Jianbo Wu
This network shows the impact of papers produced by Jianbo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianbo Wu. The network helps show where Jianbo Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianbo Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 4 | |
| 10 | The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy | 2022 | 14 |
| 11 | 2022 | 11 | |
| 12 | 2022 | 25 | |
| 13 | 2022 | 9 | |
| 14 | 2022 | 11 | |
| 15 | 2016 | 5 | |
| 16 | 2015 | 34 | |
| 17 | 2012 | 42 | |
| 18 | Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance. | 2005 | 9 |
| 19 | 2005 | 26 | |
| 20 | 2003 | 43 |
About Jianbo Wu
Jianbo Wu is a scholar working on Cancer Research, Immunology and Allergy and Hematology, having authored 117 papers that have together received 2.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (20 papers), MicroRNA in disease regulation (15 papers), Adipokines, Inflammation, and Metabolic Diseases (15 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers), Protease and Inhibitor Mechanisms (12 papers), Cell Adhesion Molecules Research (12 papers), Advanced Glycation End Products research (10 papers) and Platelet Disorders and Treatments (8 papers). The work is most often cited by research in Cancer Research (481 citations), Internal Medicine (96 citations) and Immunology and Allergy (94 citations). Jianbo Wu has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Mao Luo, Ni Chen, Salman M. Hyder, Meiping Ren, Youkun Zheng, Xin Deng, Liqun Wang, William P. Fay, Hui Jiang and Xuemei Wang. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.